-
421
Quality and safety requirements for pharmacy-based vaccination in resource-limited countries
Published 2025-02-01Subjects: Get full text
Article -
422
Global dynamics of a vaccination model for infectious diseases with asymptomatic carriers
Published 2016-04-01Subjects: Get full text
Article -
423
Awareness of Healthcare Providers About COVID-19 Vaccinations in Karbala City
Published 2022-11-01Subjects: Get full text
Article -
424
Ending vaccine hegemony: Rethinking foreign aid in global health responses
Published 2025-01-01Get full text
Article -
425
Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine.
Published 2013-11-01“…A toxicology study of the vaccine formulations planned for human use performed in rabbits showed no vaccine-related pathological changes and all animals remained healthy. …”
Get full text
Article -
426
Global Dynamics of an SVEIR Model with Age-Dependent Vaccination, Infection, and Latency
Published 2018-01-01“…In this paper, we propose an SVEIR epidemic model with age-dependent vaccination, latency, and infection. The model also considers that the waning vaccine-induced immunity depends on vaccination age and the vaccinated individuals fall back to the susceptible class after losing immunity. …”
Get full text
Article -
427
Equity in vaccination against COVID-19: Lessons from child immunization
Published 2022-04-01Get full text
Article -
428
The Impact of T Cell Vaccination in Alleviating and Regulating Systemic Lupus Erythematosus Manifestation
Published 2016-01-01“…Conclusions. T cell vaccination is helpful in alleviating and regulating systemic lupus erythematosus manifestation.…”
Get full text
Article -
429
Ending vaccine hegemony: Rethinking foreign aid in global health responses.
Published 2025-01-01Get full text
Article -
430
COVID-19 Vaccination Status and Pregnancy Outcome during Third Wave
Published 2023-08-01Subjects: Get full text
Article -
431
SHASI-ML: a machine learning-based approach for immunogenicity prediction in Salmonella vaccine development
Published 2025-02-01Subjects: Get full text
Article -
432
-
433
-
434
Immunobridging Trials: An Important Tool to Protect Vulnerable and Immunocompromised Patients Against Evolving Pathogens
Published 2024-12-01Subjects: Get full text
Article -
435
A pH-responsive PROTAC-based nanosystem triggers tumor-specific ferroptosis to construct in situ tumor vaccines
Published 2025-04-01Subjects: “…In situ tumor vaccines…”
Get full text
Article -
436
Developing an Effective Therapeutic HPV Vaccine to Eradicate Large Tumors by Genetically Fusing Xcl1 and Incorporating IL-9 as Molecular Adjuvants
Published 2025-01-01Subjects: Get full text
Article -
437
-
438
-
439
Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
Published 2025-01-01Subjects: “…HIV-1 vaccine…”
Get full text
Article -
440
Visual analysis of the research frontiers, hotspots and development trends of immunization programs for women and children
Published 2025-12-01Subjects: Get full text
Article